Abolis
PrivateLast Round
VC Round
Sep 12, 2024
Total Funding Raised
$2.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Abolis is a biotechnology company that specializes in bio-synthesis processes to optimize microorganism metabolism for the industrial production of complex molecular entities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abolis Comparables
Compare Abolis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EV Biotech | 83% | |
| Acies Bio | 83% | |
| Amyris | 80% |
Abolis Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Abolis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICOS Capital | VC Round |
| DeepTech & Climate Fonds | VC Round |
| Liberset | VC Round |
| Clay Capital | VC Round |
| Evonik Venture Capital | VC Round |
| BOLD (Business Opportunities for L'Oréal Development) | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2026
M.I.N.E. software solution was formerly known as Microbiome Studio.
- Jul 5, 2026
Felipe Sarmiento appointed Head of Business Development in the US.
Recent news
Latest coverage and updates
- launchesOct 2, 2026
Abolis Biotechnologies SAS launches the Microbial Intelligence Explorer for cosmetics formulation in France on Oct 2nd '26
- launchesOct 1, 2026
Abolis Biotechnologies SAS launches MINE, a microbial intelligence platform that combines genomic, multi-omics, experimental, and industrial data to help food and nutrition manufacturers accelerate fermentation-derived ingredient development and reduce R&D trial-and-error.
Abolis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abolis's valuation, stock price, and market status.
Is Abolis a public or private company?
Abolis is a private company.
What is the current stock price of Abolis?
Abolis is a private company, so its shares have no public market price. Caplight tracks Abolis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abolis worth (valuation)?
Valuation information for Abolis is not publicly available.
Can I buy Abolis stock?
Abolis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abolis's last funding round?
Abolis's most recent funding round was VC Round on September 12, 2024.
Who are the main investors in Abolis?
Key investors in Abolis include DeepTech & Climate Fonds, Evonik Venture Capital, BOLD (Business Opportunities for L'Oréal Development).
Will Abolis IPO soon?
No public IPO plans have been announced for Abolis.
How can I track Abolis secondary market activity?
Caplight tracks bids, offers, and trades in Abolis's shares on secondary markets.